Cergentis: Changes in Management
Utrecht-based Cergentis announced the appointment of Joris Schuurmans as new CEO.
ADVERTISEMENT
About Michael Kuhrt
This author has not written his bio yet.
But we are proud to say that Michael Kuhrt contributed 541 entries already.
Entries by Michael Kuhrt
BioAscent strengthens US business
Nick Moore now supports Scottish BioAscent Discovery Ltd. in further developing its business in North America.
Biognosys appoints new Chairman
Schlieren-based proteomics specialist Biognosys AG announces the appointment of Dr Patrick Vink as Chairman of the board.
New CEO at Ipsen
David Loew, formerly executive vice president of Sanofi Pasteur, was appointed as CEO of French Ipsen Pharma SA at the beginning of July.
New Chief Business Officer for MaaT Pharma
Dr Savita Bernal joined the Lyon-based MaaT Pharma as new Chief Business Officer.
Evox Therapeutics appoints Chief Medical Officer
Oxford-based Evox Therapeutics appoints Sonya Montgomery in the newly formed position of Chief Medical Officer.
Non-Executive Director for Redx Pharma
From the beginning of July, Sarah Gordon Wild will be an Independent non-Executive Director at Redx Pharma in Alderley Park, UK.
Genentech: New Head of Research and Early Development
Aviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July.
New CEO at Deinove
Montpellier-based Deinove has named a new Chief Executive Officer. Alexis Rideau took over the helm of the company in the beginning of May.
From Novartis to Syncona
London-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April.